| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;113:2871-2879.)
© 2006 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
From the Division of Cardiovascular Diseases (P.A.F., T.M.M.) and the Division of Biostatistics (R.L.M., W.R.B.), Mayo Clinic, Rochester, Minn; Electrophysiology, Trinity Medical Center, Rock Island, Ill (H.A.); Electrophysiology and Cardiac Pacing, Austin Heart, Austin, Tex (D.K.); Cardiology/Electrophysiology, Watson Clinic, Lakeland, Fla (N.G.K.); Internal Medicine/Cardiology, Virginia Commonwealth University, Richmond (M.W.); Cardiovascular Disease, MidWest Research Foundation, Riverside Methodist Hospital, Columbus, Ohio (E.D.); Center for Cardiac Arrhythmias and Electrophysiology, Texas Heart Institute, Houston (A.M.); Cardiology, Henry Ford Hospital, Detroit, Mich (C.S.); Maryland Heart Center, University of Maryland Medical Center, Baltimore (S.S.); Cardiovascular Disease, The Cleveland Clinic Foundation, Cleveland, Ohio (B.W.); and Electrophysiology and Pacing, Heart Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (M.G.).
Correspondence to Paul A. Friedman, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
Received October 19, 2005; revision received February 17, 2006; accepted April 7, 2006.
Background Delivery of inappropriate shocks caused by misdetection of supraventricular tachycardia (SVT) remains a substantial complication of implanted cardioverter/defibrillator (ICD) therapy. Whether use of optimally programmed dual-chamber ICDs lowers this risk compared with that in single-chamber ICDs is not clear.
Methods and Results Subjects with a clinical indication for ICD (n=400) at 27 participating centers received dual-chamber ICDs and were randomly assigned to strictly defined optimal single- or dual-chamber detection in a single-blind manner. Programming minimized ventricular pacing. The primary end point was the proportion of SVT episodes inappropriately detected from the time of programming until crossover or end of study. On a per-episode basis, 42% of the episodes in the single-chamber arm and 69% of the episodes in the dual-chamber arm were due to SVT. Mortality (3.5% in both groups) and early study withdrawal (14% single-chamber, 11% dual-chamber) were similar in both groups. The rate of inappropriate detection of SVT was 39.5% in the single-chamber detection arm compared with 30.9% in the dual-chamber arm. The odds of inappropriate detection were decreased by almost half with the use of the dual-chamber detection enhancements (odds ratio, 0.53; 95% confidence interval, 0.30 to 0.94; P=0.03).
Conclusions Dual-chamber ICDs, programmed to optimize detection enhancements and to minimize ventricular pacing, significantly decrease inappropriate detection.
Related Article:
This article has been cited by other articles:
![]() |
J. Toquero, J. Alzueta, L. Mont, I. F. Lozano, A. Barrera, A. Berruezo, V. Castro, J. L. Pena, M. L. Fidalgo, and J. Brugada Morphology discrimination criterion wavelet improves rhythm discrimination in single-chamber implantable cardioverter-defibrillators: Spanish Register of morphology discrimination criterion wavelet (REMEDIO) Europace, June 1, 2009; 11(6): 727 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Lin, R A Nishimura, B J Gersh, D Phil, S R Ommen, M J Ackerman, and P A Brady Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy Heart, May 1, 2009; 95(9): 709 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Olshansky, R. Gopinathannair, and R. M. Sullivan DAVID II did not slay Goliath. J. Am. Coll. Cardiol., March 10, 2009; 53(10): 881 - 883. [Full Text] [PDF] |
||||
![]() |
S. Tzeis, G. Andrikopoulos, C. Kolb, and P. E. Vardas Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks Europace, November 1, 2008; 10(11): 1256 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Gronefeld Discrimination of ventricular tachycardia from supraventricular tachycardia in implantable cardioverter defibrillators by automated electrogram morphology analysis: can leads finally replace the electrophysiologist? Europace, October 1, 2008; 10(10): 1131 - 1132. [Full Text] [PDF] |
||||
![]() |
G. Boriani, E. Occhetta, S. Cesario, S. Grossi, M. Marconi, G. Speca, P. Silvestri, M. Biffi, M. Bortnik, C. Martignani, et al. Contribution of morphology discrimination algorithm for improving rhythm discrimination in slow and fast ventricular tachycardia zones in dual-chamber implantable cardioverter-defibrillators Europace, August 1, 2008; 10(8): 918 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): e350 - e408. [Full Text] [PDF] |
||||
![]() |
L. van Erven and M. J Schalij Troubleshooting implantable cardioverter-defibrillator related problems Heart, May 1, 2008; 94(5): 649 - 660. [Full Text] [PDF] |
||||
![]() |
J. Almendral, F. Arribas, C. Wolpert, R. Ricci, P. Adragao, E. Cobo, X. Navarro, A. Quesada, and the DATAS Steering Committee and Writing Committee Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial Europace, May 1, 2008; 10(5): 528 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Daubert, W. Zareba, D. S. Cannom, S. McNitt, S. Z. Rosero, P. Wang, C. Schuger, J. S. Steinberg, S. L. Higgins, D. J. Wilber, et al. Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II: Frequency, Mechanisms, Predictors, and Survival Impact J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1357 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Worck, J. Haarbo, and P. E. B. Thomsen Electrophysiological study and 'slow' ventricular tachycardia predict appropriate therapy: results from a single-centre implantable cardiac defibrillator follow-up Europace, November 1, 2007; 9(11): 1048 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ezekowitz, B. H. Rowe, D. M. Dryden, N. Hooton, B. Vandermeer, C. Spooner, and F. A. McAlister Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction Ann Intern Med, August 21, 2007; 147(4): 251 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Passman and A. Kadish Sudden Death Prevention With Implantable Devices Circulation, July 31, 2007; 116(5): 561 - 571. [Full Text] [PDF] |
||||
![]() |
M. H. Schoenfeld Contemporary Pacemaker and Defibrillator Device Therapy: Challenges Confronting the General Cardiologist Circulation, February 6, 2007; 115(5): 638 - 653. [Full Text] [PDF] |
||||
![]() |
R. L McClelland, W. R Bamlet, M. Glikson, and P. A Friedman Design and analysis issues in cardiac arrhythmia trials: insights from the Detect Supraventricular Tachycardia Trial Clinical Trials, February 1, 2007; 4(1): 74 - 80. [Abstract] [PDF] |
||||
![]() |
A. K. Gehi, D. Mehta, and J. A. Gomes Evaluation and Management of Patients After Implantable Cardioverter-Defibrillator Shock JAMA, December 20, 2006; 296(23): 2839 - 2847. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Sweeney Overcoming the Defects of a Virtue: Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis: The Detect Supraventricular Tachycardia Study Circulation, June 27, 2006; 113(25): 2862 - 2864. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |